SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-463448
Filing Date
2012-11-09
Accepted
2012-11-09 16:36:42
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d410703d10q.htm 10-Q 301197
2 RETENTION BONUS AGREEMENT d410703dex101.htm EX-10.1 13840
3 SECTION 302 CEO CERTIFICATION d410703dex311.htm EX-31.1 8266
4 SECTION 302 CFO CERTIFICATION d410703dex312.htm EX-31.2 8457
5 SECTION 906 CEO AND CFO CERTIFICATION d410703dex321.htm EX-32.1 4274
  Complete submission text file 0001193125-12-463448.txt   2454658

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT myrx-20120930.xml EX-101.INS 305281
7 XBRL TAXONOMY EXTENSION SCHEMA myrx-20120930.xsd EX-101.SCH 34113
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE myrx-20120930_cal.xml EX-101.CAL 40270
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE myrx-20120930_def.xml EX-101.DEF 146591
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE myrx-20120930_lab.xml EX-101.LAB 207506
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myrx-20120930_pre.xml EX-101.PRE 173095
Mailing Address 305 CHIPETA WAY SALT LAKE CITY UT 84108
Business Address 305 CHIPETA WAY SALT LAKE CITY UT 84108 801-214-7800
Myrexis, Inc. (Filer) CIK: 0001459450 (see all company filings)

IRS No.: 263996918 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-34275 | Film No.: 121194182
SIC: 2834 Pharmaceutical Preparations